tiprankstipranks
Trending News
More News >
Ocumension Therapeutics (HK:1477)
:1477
Hong Kong Market

Ocumension Therapeutics (1477) Income Statement

Compare
1 Followers

Ocumension Therapeutics Income Statement

Last quarter (Q2 2025), Ocumension Therapeutics's total revenue was ¥294.03M, an increase of 183.55% from the same quarter last year. In Q2, Ocumension Therapeutics's net income was ¥-132.32M. See Ocumension Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 417.31M¥ 246.37M¥ 158.96M¥ 56.15M¥ 13.10M
Gross Profit
¥ 225.06M¥ 144.37M¥ 102.92M¥ 36.94M¥ 11.37M
Operating Expenses
¥ 529.14M¥ 546.51M¥ 558.78M¥ 422.48M¥ 499.20M
Depreciation and Amortization
¥ 77.07M¥ 57.54M¥ 40.46M¥ 9.62M¥ 4.65M
EBITDA
¥ -188.03M¥ -320.62M¥ -359.98M¥ -249.81M¥ -2.26B
Operating Income
¥ -306.43M¥ -402.15M¥ -455.86M¥ -385.20M¥ -451.72M
Other Income/Expenses
¥ 39.17M¥ 21.86M¥ 53.63M¥ 125.55M¥ -1.81B
Pretax Income
¥ -267.26M¥ -379.48M¥ -402.23M¥ -259.99M¥ -2.26B
Net Income
¥ -268.27M¥ -379.79M¥ -402.64M¥ -259.99M¥ -2.26B
Per Share Metrics
Basic EPS
¥ -0.39¥ -0.59¥ -0.64¥ -0.43¥ -7.47
Diluted EPS
¥ -0.39¥ -0.59¥ -0.64¥ -0.43¥ -7.47
Weighted Average Shares Outstanding
687.88M 649.19M 632.53M 607.14M 302.35M
Weighted Average Shares Outstanding (Diluted)
687.88M 649.19M 632.53M 607.14M 302.35M
Currency in CNY

Ocumension Therapeutics Earnings and Revenue History